Sponsors (14)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Requires the Department of Health and Human Services to study how and when hospital emergency departments test overdose patients for fentanyl and related substances, including costs, benefits, risks, privacy, staffing, and implementation barriers, and to issue guidance within nine months after completing the study. Also includes a short-title clause allowing the statute to be referred to by a formal short name in citations and communications.
The bill encourages and studies routine fentanyl testing in emergency settings—which could improve overdose treatment and clinician decision-making and provide implementation guidance—but it also raises privacy concerns, cost and staffing burdens, the risk that testing deters people from seeking ERs
People experiencing overdose will likely receive more informed, potentially improved treatment if routine fentanyl testing is adopted and used to guide care.
Emergency department clinicians will have clearer test information to make better-informed clinical decisions during overdose care.
Hospital emergency departments (including freestanding EDs) will receive federal guidance and a catalog of resources that can lower implementation and administrative burdens for adopting testing.
People who use drugs and overdose patients may avoid or delay calling for emergency care if routine drug testing becomes expected during treatment.
Hospitals, taxpayers, payers, and patients may face increased costs to implement routine testing (equipment, training, staffing), straining budgets and resources.
Collecting and storing drug-test results raises privacy and HIPAA risks for patients if protections are not fully clarified and enforced.
Introduced March 10, 2025 by James E. Banks · Last progress March 24, 2026